Matthew Kelsey

Stock Analyst at HC Wainwright & Co.

(0.66)
# 3,936
Out of 4,911 analysts
7
Total ratings
50%
Success rate
-15.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Kelsey

Sensei Biotherapeutics
Jun 2, 2025
Assumes: Buy
Price Target: $100
Current: $6.98
Upside: +1,332.66%
Acurx Pharmaceuticals
May 15, 2025
Assumes: Buy
Price Target: $8
Current: $0.41
Upside: +1,870.93%
DBV Technologies
Dec 20, 2018
Maintains: Equal-Weight
Price Target: $260$100
Current: $9.46
Upside: +957.63%